Consequences of partial duplications of the human CFTR gene on cf diagnosis: Mutations or ectopic variations  Ayman El-Seedy, Marie-Claude Pasquet, Thiery.

Slides:



Advertisements
Similar presentations
Wilson disease as a cause of liver injury in cystic fibrosis
Advertisements

Comparing age of cystic fibrosis diagnosis and treatment initiation after newborn screening with two common strategies  Don B. Sanders, Huichuan J. Lai,
Cheryl Cameron, Mark W. Lodes, William M. Gershan 
A wide methodological approach to identify a large duplication in CFTR gene in a CF patient uncharacterised by sequencing analysis  Lucy Costantino, Damiana.
The Spectrum of CFTR Variants in Nonwhite Cystic Fibrosis Patients
Analysis of the CFTR gene in Iranian cystic fibrosis patients: Identification of eight novel mutations  Reza Alibakhshi, Roya Kianishirazi, Jean-Jacques.
Cystic Fibrosis Screen Positive, Inconclusive Diagnosis (CFSPID): A new designation and management recommendations for infants with an inconclusive diagnosis.
P. Whitaker, N. Shaw, J. Gooi, C. Etherington, S. Conway, D. Peckham 
CFTR mutation in an Arab patient: Clinical and functional features of 875+1G→A/875+1G→A genotype  Elide Spinelli, Manuela Seia, Paola Melotti, Eleonora.
Splicing defects in the CFTR gene: Minigene analysis of two mutations, G>C and A>G  Gwendal Dujardin, Diane Commandeur, Catherine Le Jossic-Corcos,
Detection of two Alu insertions in the CFTR gene
Cystic fibrosis: A new mutation in the Lebanese population
Use of high-dose ibuprofen in a pediatric cystic fibrosis center
K. L. Nash, M. E. Allison, D. McKeon, D. J. Lomas, C. S. Haworth, D
Abaigeal D. Jackson, Christopher H. Goss  Journal of Cystic Fibrosis 
Influence of the Duplication of CFTR Exon 9 and Its Flanking Sequences on Diagnosis of Cystic Fibrosis Mutations  Ayman El-Seedy, Tony Dudognon, Frédéric.
Impact of storage conditions on metabolite profiles of sputum samples from persons with cystic fibrosis  Jiangchao Zhao, Charles R. Evans, Lisa A. Carmody,
Detection of an Apparent Homozygous 3120G>A Cystic Fibrosis Mutation on a Routine Carrier Screen  Denise LaMarche Heaney, Patrick Flume, Lauren Hamilton,
Spectrum of mutations in CFTR in Finland: 18 years follow-up study and identification of two novel mutations  Satu Kinnunen, Sandra Bonache, Teresa Casals,
Successful treatment of cepacia syndrome
CFTR gene analysis in Latin American CF patients: Heterogeneous origin and distribution of mutations across the continent  Martín M. Pérez, María Cecilia.
Urinary incontinence in 9���16��year olds with cystic fibrosis compared to other respiratory conditions and a normal group  W.J. Browne, C.J. Wood, M.
Nadav Traeger, Qiuhu Shi, Allen J. Dozor  Journal of Cystic Fibrosis 
Measures of body habitus are associated with lung function in adults with cystic fibrosis: A population-based study  Doug L. Forrester, Alan J. Knox,
Laura Viviani, Baroukh M. Assael, Eitan Kerem 
Cirrhosis and other liver disease in cystic fibrosis
Katelyn Krivchenia, Don Hayes, Joseph D. Tobias, Dmitry Tumin 
Alexandra Scott, Hanna M
Characterization of a recurrent 3
Anju Anand, Elizabeth Tullis, Anne Stephenson, Preyanka Abhyankar 
D. Stevens, P.J. Oades, N. Armstrong, C.A. Williams 
Claire J. Tipping, Rebecca L. Scholes, Narelle S. Cox 
Comparison of real time diagnostic chemistries to detect Pseudomonas aeruginosa in respiratory samples from cystic fibrosis patients  J.L. Fothergill,
WGA Allows the Molecular Characterization of a Novel Large CFTR Rearrangement in a Black South African Cystic Fibrosis Patient  Marie des Georges, Caroline.
Vitamin A and lung function in CF
Clinical presentation of mild cystic fibrosis in a Serbian patient homozygous for the CFTR mutation c G>A  Aleksandra Nikolic, Nedeljko Radlovic,
Laurent Gouya  Journal of Investigative Dermatology 
A.H. Gifford  Journal of Cystic Fibrosis 
M. Wouthuyzen-Bakker, F.A.J.A. Bodewes, H.J. Verkade 
Demographics of glucose metabolism in cystic fibrosis
Inhalation solutions — Which ones may be mixed
Wilson disease as a cause of liver injury in cystic fibrosis
Cystic fibrosis mutations and genotype–pulmonary phenotype analysis
Characterisation of mutations and genotype–phenotype correlation in cystic fibrosis: Experience from India  Shivaram S. Shastri, Madhulika Kabra, Sushil.
Sophia L. Markantonis, Anna Katelari, Eleni Pappa, Stavros Doudounakis 
E. Tschiedel, H. Grasemann, F. Ratjen  Journal of Cystic Fibrosis 
Colon Cancer in Cystic Fibrosis patients: Is this a growing problem?
A recurrent deep-intronic splicing CF mutation emphasizes the importance of mRNA studies in clinical practice  Catherine Costa, Virginie Pruliere-Escabasse,
Cystic fibrosis transmembrane conductance regulator gene variants are associated with autoimmune pancreatitis and slow response to steroid treatment 
Sally H. Pattison, Geraint B. Rogers, Martin Crockard, J
Validation of High-Resolution DNA Melting Analysis for Mutation Scanning of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene  Marie-Pierre.
Nasal polyposis in lung transplant recipients with cystic fibrosis
Chee Y. Ooi, Peter R. Durie  Journal of Cystic Fibrosis 
Novel concepts in evaluating antimicrobial therapy for bacterial lung infections in patients with cystic fibrosis  Geraint B. Rogers, Lucas R. Hoffman,
Effect of ivacaftor in patients with advanced cystic fibrosis and a G551D-CFTR mutation: Safety and efficacy in an expanded access program in the United.
Nutritional decline in cystic fibrosis related diabetes: The effect of intensive nutritional intervention  H. White, K. Pollard, C. Etherington, I. Clifton,
Trends in pathogens colonising the respiratory tract of adult patients with cystic fibrosis, 1985–2005  F.A. Millar, N.J. Simmonds, M.E. Hodson  Journal.
F. Vermeulen, P. Lebecque, K. De Boeck, T. Leal 
Determining presence of lung disease in young children with cystic fibrosis: Lung clearance index, oxygen saturation and cough frequency  E.M. Bakker,
Comparing age of cystic fibrosis diagnosis and treatment initiation after newborn screening with two common strategies  Don B. Sanders, Huichuan J. Lai,
J.E. Spahr, R.B. Love, M. Francois, K. Radford, K.C. Meyer 
CFTR modulators and pregnancy: Our work has only just begun
Beta-lactam allergy in adults with cystic fibrosis
Cheryl Cameron, Mark W. Lodes, William M. Gershan 
Lutz Goldbeck, Sven Zerrer, Tim G. Schmitz  Journal of Cystic Fibrosis 
David Adeboyeku, Sandra Scott, Margaret E. Hodson 
Mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) in Chinese patients with congenital bilateral absence of vas deferens  Hongjun.
Increasing resistance of the Liverpool Epidemic Strain (LES) of Pseudomonas aeruginosa (Psa) to antibiotics in cystic fibrosis (CF)—A cause for concern? 
Elisabeth P. Dellon, Margaret W. Leigh, James R. Yankaskas, Terry L
Absence of a gender gap in survival
Presentation transcript:

Consequences of partial duplications of the human CFTR gene on cf diagnosis: Mutations or ectopic variations  Ayman El-Seedy, Marie-Claude Pasquet, Thiery Bienvenu, Eric Bieth, Marie-Pierre Audrezet, Alain Kitzis, Véronique Ladeveze  Journal of Cystic Fibrosis  Volume 12, Issue 4, Pages 407-410 (July 2013) DOI: 10.1016/j.jcf.2012.11.006 Copyright © 2012 European Cystic Fibrosis Society. Terms and Conditions

Fig. 1 CFTR exon 10 region and its duplicated sequences in the human genome. (a) Localization of CFTR mutations found in duplicated sequences of exon 10 and its intronic flanking regions. These variants may be due to the sequence identity with similar sequences in the human genome that markedly increase priming artifacts. (b) Chromosomal location of CFTR exon 10 on chromosome 7 and the duplicated CFTR exon 10 regions. The positions in these sequences of the previously described CFTR mutations are shown (arrowheads). The black triangles indicate mutations found in all duplicated sequences and that are not CFTR exon 10 mutations. The black circles indicate location of the CFTR mutations not tested in this study. The black squares show tested and authentic mutations. Journal of Cystic Fibrosis 2013 12, 407-410DOI: (10.1016/j.jcf.2012.11.006) Copyright © 2012 European Cystic Fibrosis Society. Terms and Conditions

Fig. 2 DNA sequence of exon 10 from the examined patients: c.1392G>T (a), c.1247A>G (b) and c.1235delC (c) mutations. The black points indicate these mutations. For the c.1235delC (c) mutations, the deletion induces a frameshift, visible at the left of the mutation. Journal of Cystic Fibrosis 2013 12, 407-410DOI: (10.1016/j.jcf.2012.11.006) Copyright © 2012 European Cystic Fibrosis Society. Terms and Conditions